Agrastat

Agrastat (Tirofiban Hydrochloride Monohydrate) is an intravenous medication used for managing acute coronary syndrome. This EU-manufactured drug helps prevent blood clots in certain heart conditions.

Agrastat is primarily used to reduce the risk of heart attack or other complications in patients with acute coronary syndrome. It works by preventing platelets from sticking together and forming clots. This medication is often administered in hospital settings for short-term use during procedures like angioplasty.

Common effects of Agrastat may include bleeding, bruising, or prolonged bleeding from cuts. Some patients might experience nausea, headache, or dizziness. These effects are generally mild and temporary, but severe reactions should be reported to a healthcare provider immediately.

Agrastat should be used with caution in patients with a history of bleeding disorders or recent surgery. It is important to monitor for signs of bleeding while using this medication. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.

Agrastat may interact with other blood-thinning medications, such as warfarin or aspirin, increasing the risk of bleeding. It is also important to avoid nonsteroidal anti-inflammatory drugs (NSAIDs) while using Agrastat, as they can further increase bleeding risk. Always consult a healthcare provider before combining medications.